Flow Chemistry Market Estimated Worth at .9 Billion by 2028

Posted by Jack Martin on June 27th, 2023

The flow chemistry market size is projected to grow from USD 1.7 billion in 2022 to USD 2.9 billion by 2028, registering a CAGR of 10.4% during the forecast period. This growth is attributed to the increasing demand for efficient and sustainable chemical manufacturing processes, as well as the growing interest in the synthesis of complex molecules, such as pharmaceutical intermediates and specialty chemicals, further fuels the demand for flow chemistry. The pharmaceutical industry is a significant driver of flow chemistry adoption. The increasing demand for new drug candidates, coupled with the need for efficient and cost-effective synthesis methods, has fueled the use of flow chemistry in pharmaceutical manufacturing. Flow chemistry enables streamlined synthesis routes, rapid optimization, and improved yield and purity of pharmaceutical intermediates and active pharmaceutical ingredients (APIs). 

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1316 

Players have adopted different strategies to strengthen their market positions and ensure long-term growth and success. These strategies enable them to efficiently meet the growing demand for reactor’s and purification method by various industries. Also, companies operating in this market, such as Thermo Fisher Scientific Inc (US), Corning Incorporated (US), Lonza (Switzerland), PerkinElmer Inc (US), Biotage (Sweden), adopt acquisitions, new product launch, agreement, expansions, collaborations, and partnerships to increase their market shares and expand their geographic presence.

Thermo Fisher Scientific (US) is a global leader in the life sciences business, with annual revenue of more than billion and a diverse variety of products and services that enable scientific study and discovery across a wide range of applications. With its strong regional presence and expertise in flow chemistry, the company is well-positioned to continue its expansion and success in the years ahead. It offers a variety of goods and services to customers in the pharmaceutical, biotechnology, academic, and government sectors. Thermo Electron Corporation and Fisher Scientific International merged to form the company in 2006, and it has since evolved to become a leading provider of scientific research products and services globally. Thermo Fisher Scientific offers a comprehensive range of products and services, including laboratory equipment and supplies, analytical instruments, reagents and consumables, software and services, and specialist diagnostics. The company's products are used in a wide range of applications, including drug discovery and development, clinical research, and environmental studies. Thermo Fisher Scientific has a substantial presence in North America, Europe, and Asia, and operates in over 50 countries globally. The company has a global network of sales and service personnel, as well as production and distribution facilities, allowing it to serve consumers in practically every country.